Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives

Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives

The expression of estrogen receptors (ERs) in breast cancer (BC) represents a strong prognostic and predictive biomarker and directs therapeutic decisions in early and advanced stages. ER-low-positive BC, defined by the immunohistochemical (IHC) expression of ERs from 1% to 9%, constitutes a distinc...

Full description

Bibliographic Details
Main Authors: Christina Panagiotis Malainou, Nikolina Stachika, Aikaterini Konstantina Damianou, Aristotelis Anastopoulos, Ioanna Ploumaki, Efthymios Triantafyllou, Konstantinos Drougkas, Georgia Gomatou, Elias Kotteas
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Current Oncology
Subjects:
estrogen receptor
breast cancer
estrogen receptor-low-positive breast cancer
endocrine therapy
triple-negative breast cancer
Online Access:https://www.mdpi.com/1718-7729/30/11/706

Internet

https://www.mdpi.com/1718-7729/30/11/706

Similar Items